Medical Progress Today
mpt home | sign up

Volume 4, Number 1
January 5, 2007


PRINTER FRIENDLY

News

AIDS drugs offer hope but too late for one man
Los Angeles Times, 1-2-07

Editor's Notes:

George Orwell died of tuberculosis in 1950, just as a combination antibiotic regimen was being developed that would’ve saved his life. As James LeFanu, a Canadian writer, puts it, "Orwell died on the cusp of a paradigm shift [in tuberculosis treatment.]"
Continue reading . . .

Millions save money on Medicare Program
Associated Press Newswires, 1-1-07

Editor's Notes:

The Democrats, as part of their "100 hours" agenda, have promised to pass a bill requiring the Secretary of Health and Human Services to negotiate with manufacturers for the Part D drug benefit. While it is not clear how these negotiations would be conducted, especially in the absence of a Medicare approved drug formulary, the Democrats seem determined to pass the bill and it may have the votes to reach the President's desk.
Continue reading . . .

Health Care Gold Mines: Middlemen Strike it Rich
Wall Street Journal, 12-29-06

Editor's Notes:

New York Times columnist Paul Krugman often argues that Medicare and other government health programs are more efficient than private providers because they have lower administrative costs—i.e., they cut out advertising and the need for "middlemen" to monitor costs.
Continue reading . . .

McMedical Care
Governing Magazine, 12-1-06

Editor's Notes:

The December issue of Governing magazine focuses on the growing phenomenon of small, retail health clinics that offer a wide range of basic health services at a fraction of the cost of a traditional doctor's office. This is just one small but powerful example of how market forces applied to health care can cut costs and improve consumer satisfaction.
Continue reading . . .

Commentary

Pharma in Europe: Going from Heartburn to Heart Attack?
Jurgen Reinhoudt, The American, 1-4-07

(This commentary was selected for the Weekly Health Blog Carnival,
1-09-07 and by the Health Wonk Review, 1-10-07)
Continue reading . . .

Review and Outlook: The 100 Hours Rush
Wall Street Journal, 1-4-07

The Journal reviews the legislation that Democrats have promised to pass in their first 100 hours in control of Congress, and suggest the nation deserves more of a debate on these issues than it will get.
Continue reading . . .

Business Bookshelf: Why Biotech's Promise is so great, but not its profits (so far)
Andy Kessler, Wall Street Journal, 1-3-07

In this book review, Kessler, the author of The End of Medicine, offers his thoughts on why biotech companies can't offer—at least not yet—a magic bullet that could cut the enormous financial costs and risks of drug development.
Continue reading . . .

Don't infect Medicare with Price Controls
Deroy Murdock, Union Leader, 1-1-07

Murdock explains why policymakers who want to make the Medicare drug benefit more like the Veteran’s Administration National Formulary—with attendant price controls—risk inflicting serious harm on consumers and the industry that supplies Americans with vital new medicines.
Continue reading . . .

Letting Medicare use its bargaining power would send a strong message that drug prices are unsustainably high
Susan Stranahan, AARP, 1-1-07

The AARP weighs in with its support for drug price negotiations in the Medicare drug benefit, a position with which we disagree—but one held by many policymakers. But the AARP also recognizes that the VA model is not a good one for seniors.
Continue reading . . .

Taking Cola to Court
Walter K. Olson, City Journal, 12-1-06

In the Winter issue of the Manhattan Institute's City Journal, Walter Olson examines how plaintiff's attorneys are plotting their next (extremely lucrative) litigation campaign against American corporations—and finds tort lawyers hoping that Coke is the Real Thing.
Continue reading . . .


Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

In this week's issue:

NEWS

AIDS drugs offer hope but too late for one man
Millions save money on Medicare Program
Health Care Gold Mines: Middlemen Strike it Rich
McMedical Care

COMMENTARY

Pharma in Europe: Going from Heartburn to Heart Attack?
Review and Outlook: The 100 Hours Rush
Business Bookshelf: Why Biotech's Promise is so great, but not its profits (so far)
Don't infect Medicare with Price Controls
Letting Medicare use its bargaining power would send a strong message that drug prices are unsustainably high
Taking Cola to Court
Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org